Related Experiment Videos
Miconazole in oral candidiasis.
1Radium Centre, Odense Hospital, Denmark.
Proceedings of the Royal Society of Medicine
|January 1, 1977
Summary
Oral miconazole effectively treated oral candidiasis in 35 episodes across 24 patients, including those with leukemia. This antifungal medication showed a high cure rate with no observed side effects.
Area of Science:
- Mycology
- Pharmacology
- Infectious Diseases
Background:
- Oral candidiasis is a common opportunistic infection, particularly in immunocompromised patients.
- Patients with leukemia are at high risk due to granulocytopenia and immunosuppressive therapies (prednisolone, antibiotics).
- Existing antifungal treatments may have limitations or side effects.
Purpose of the Study:
- To evaluate the efficacy and safety of oral miconazole in treating oral candidiasis.
- To assess the cure rates and recurrence patterns of oral miconazole treatment.
- To compare oral miconazole with other available antimycotic preparations.
Main Methods:
- A study involving 24 patients with 35 episodes of oral candidiasis.
- Treatment administered: oral miconazole (250 mg).
- Patient population included individuals with various forms of leukemia and other predisposing factors.
Main Results:
- 100% clinical cure rate observed across all 35 treated episodes.
- Mean treatment duration was five days, with clinical improvement in two to three days.
- 97% mycological cure rate when protocol violators were excluded; 21 recurrences noted within one month, likely due to reinfection.
- No adverse side effects were reported, even in severely debilitated patients.
Conclusions:
- Oral miconazole is a highly effective and safe treatment for oral candidiasis, even in high-risk immunocompromised patients.
- The drug demonstrates a favorable efficacy profile compared to other oral antifungal agents.
- Further investigation into recurrence prevention strategies may be warranted.